DiaMedica Therapeutics (DMAC) Prepaid Assets (2017 - 2026)
DiaMedica Therapeutics (DMAC) reported Prepaid Assets of $731000.0 for Q1 2026, up 12.63% on a YoY basis from $649000.0 in Q1 2025, and up 51.98% quarter-over-quarter from $481000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Prepaid Assets (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Prepaid Assets for 10 years, with the latest figure at $731000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 12.63% year-over-year to $731000.0; the trailing twelve-month figure through Mar 2026 stood at $731000.0 (up 12.63% YoY), and the FY2025 full-year result was $481000.0, up 111.89% from the prior year.
- Prepaid Assets for Q1 2026 stood at $731000.0, up from $481000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $962000.0 in Q1 2023, with the low at $209000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $521941.2 across 5 years, with a median of $534000.0 in 2022.
- Annual changes were most pronounced in 2024 — Prepaid Assets slumped 44.77% — and 2025, when it surged 111.89%.
- DiaMedica Therapeutics' Prepaid Assets stood at $209000.0 in 2022, then jumped by 96.65% to $411000.0 in 2023, then tumbled by 44.77% to $227000.0 in 2024, then soared by 111.89% to $481000.0 in 2025, then jumped by 51.98% to $731000.0 in 2026.
- The last three Prepaid Assets figures came in at $731000.0 (Q1 2026), $481000.0 (Q4 2025), and $445000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 731,000.00 |
| Dec 31, 2025 | 481,000.00 |
| Sep 30, 2025 | 445,000.00 |
| Jun 30, 2025 | 680,000.00 |
| Mar 31, 2025 | 649,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 569,000.00 |
| Dec 31, 2023 | 411,000.00 |
| Sep 30, 2023 | 396,000.00 |
| Jun 30, 2023 | 616,000.00 |
| Mar 31, 2023 | 962,000.00 |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 322,000.00 |
| Jun 30, 2022 | 534,000.00 |
| Mar 31, 2022 | 793,000.00 |
| Dec 31, 2021 | 197,000.00 |
| Sep 30, 2021 | 336,000.00 |
| Jun 30, 2021 | 318,000.00 |